JP Morgan Chase’s Immunogen Inc IMGN Stock Holding History

JP Morgan Chase’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,400	Closed	-$130K	–	8077
2023 Q4	$130K	Hold	4,400	–	–	﹤0.01%	5611
2023 Q3	$69.8K	Buy	+4,400	New	+$73.2K	﹤0.01%	5681
2023 Q2	–	Sell	-16,400	Closed	-$63K	–	7440
2023 Q1	$63K	Buy	+16,400	New	+$69.9K	﹤0.01%	5624
2019 Q2	–	Sell	-25,000	Closed	-$68K	–	6078
2019 Q1	$68K	Hold	25,000	–	–	﹤0.01%	5012
2018 Q4	$120K	Buy	25,000 +23,400	+1,463%	+$142K	﹤0.01%	4776
2018 Q3	$15K	Buy	+1,600	New	+$15.4K	﹤0.01%	5464
2015 Q1	–	Sell	-40,000	Closed	-$244K	–	4319
2014 Q4	$244K	Buy	+40,000	New	+$366K	﹤0.01%	3956

Other funds holding IMGN

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JP Morgan Chase's IMGN Position: Q1 2024 in Review

JP Morgan Chase sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 2,063,254 shares — an estimated $61.2M sold.

JP Morgan Chase first reported a position in IMGN in Q2 2013 and held it in 34 quarters. The position peaked at $61.2M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

JP Morgan Chase reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
JP Morgan Chase sold 2,063,254 Immunogen Inc shares in Q1 2024, an estimated $61.2M.
JP Morgan Chase first reported a position in Immunogen Inc in Q2 2013 and held it in 34 quarters.
JP Morgan Chase's Immunogen Inc position peaked at $61.2M in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.